K R Koh Selected Research

K R Koh Research Topics

5	Neoplasms (Cancer) 03/2001 - 01/2000
3	Leukemia 12/2001 - 01/2001
2	Lymphoma (Lymphomas) 12/2001 - 01/2001
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2001 - 01/2000
2	Fever (Fevers) 06/2001 - 03/2001
2	Pathologic Complete Response 01/2001 - 09/2000
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2000 - 01/2000
1	Thrombosis (Thrombus) 03/2002
1	Connective Tissue Diseases (Connective Tissue Disease) 03/2002
1	Exanthema (Rash) 06/2001
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2001
1	Hematologic Neoplasms (Hematological Malignancy) 03/2001
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2001
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2001
1	Erythema 09/2000
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 09/2000
1	Necrosis 05/2000
1	Bacterial Infections (Bacterial Infection) 05/2000
1	Neutropenia 05/2000
1	Disease Progression 01/2000

3	Interleukin-18 (Interleukin 18)IBA 01/2001 - 01/2000
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2001 - 01/2001
2	Inosine Triphosphate (ITP)IBA 06/2001 - 01/2000
2	AntigensIBA 01/2001 - 01/2001
1	Heparin (Liquaemin)FDA LinkGeneric 03/2002
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 03/2002
1	Immunoglobulin M (IgM)IBA 06/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2001
1	polyglucosanIBA 03/2001
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 01/2001
1	Surface Antigens (Surface Antigen)IBA 01/2001
1	urinastatin (MR 20)IBA 01/2001
1	LatexIBA 01/2001
1	Ficusin (Psoralen)IBA 09/2000
1	Interferon-gamma (Interferon, gamma)IBA 09/2000
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2000
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2000
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2000
1	Therapeutic UsesIBA 01/2000

5	Drug Therapy (Chemotherapy) 03/2001 - 05/2000
2	Therapeutics 03/2001 - 09/2000
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2001
1	Combination Drug Therapy (Combination Chemotherapy) 01/2001
1	Radiotherapy 09/2000
1	Aftercare (After-Treatment) 09/2000
1	PUVA Therapy 09/2000
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 09/2000